Losing
EVIDENCE · STALLED MID-TO-LATE-STAGE DEALS
- CALL · ACCT-2210 · AUG 14“Honestly there’s no rush on our side. We’ll revisit after Q1.”
- DEAL NOTE · ACCT-3187 · AUG 22Champion likes it. No budget owner identified yet.
- EMAIL · ACCT-1954 · SEP 03“Can we push the decision to next fiscal? Priorities shifted.”
- CALL · ACCT-4471 · SEP 09“What’s the cost of waiting? I’m not sure we know.”
- DEAL NOTE · ACCT-2788 · SEP 17Moved to Commit. Pain not quantified. Next step TBD.
- EMAIL · ACCT-3302 · SEP 24“It feels similar to the tools we already have.”
$38M
$38M in mid-to-late-stage pipeline stalled in Q3, representing 31% of the forecast.
Coverage is not the constraint. Only 7% of stalled deals lack multithreading. Deals are advancing without the forensic discovery that exposes material pain, quantifies its impact, and gives buyers a reason to act now.
Make documented pain, quantified impact, and urgency hard exit criteria before any deal reaches a forecast stage.
OWNER